CNN’s Table For Five exploded Saturday as host Abby Phillip attempted to explain the difference between blatant antisemitism and everyday criticism of Israel. “The Israel issue is a big one, and it’s ...

A pilot program is building solar panels over irrigation canals to generate electricity. As a bonus, the shade prevents water from evaporating. By Quinn Glabicki In California, a sprawling 4,000-mile ...

A redacted image created by Mindgard after OpenAI said it had addessed the prompt The latest public version of ChatGPT can be made to generate sexualised images or depict scenes of graphic violence ...

The Broward County School Board has unanimously approved a new school bus camera enforcement program designed to catch drivers who illegally pass stopped school buses while students are getting on or ...

There has been a sharp rise in so-called "nudification" technology. These AI-powered tools can generate realistic fake images and videos that depict people as undressed, often without their knowledge ...

The tragic incident occurred at McKinley Elementary School in Burlingame, California, on May 13, according to reports KRON 4/Youtube A young boy died after a table fell on him at an after-school ...

Companies are scrambling to deal with the glut. Credit...Mojo Wang Supported by By Mike Isaac and Erin Griffith Reporting from San Francisco When a financial services company recently began using ...

Miners who treat their Bitcoin holdings as a working asset rather than a passive reserve “will carry a structural edge into the next halving,” says Wintermute. Many Bitcoin miners are struggling to ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...